The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health•

Category: Gastrointestinal

Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development
Clinical & Manufacturing

Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development

OCT 16, 2026
GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions
Clinical & Manufacturing

GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions

SEP 11, 2026
Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data
Clinical & Manufacturing

Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data

AUG 7, 2026
Beyond the small intestine: ileo colonic delivery as the next frontier for oral therapeutics
Gastrointestinal

Beyond the small intestine: ileo colonic delivery as the next frontier for oral therapeutics

JUN 10, 2026
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for IBS
Clinical & Manufacturing

EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for IBS

APR 30, 2026
How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling
Gastrointestinal

How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling

FEB 26, 2026
Global scientific paper establishes first consensus definition of gut health
Gastrointestinal

Global scientific paper establishes first consensus definition of gut health

FEB 20, 2026
Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
Editor's Choice

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

FEB 11, 2026
EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS
Clinical & Manufacturing

EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS

JAN 8, 2026
Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome
Gastrointestinal

Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome

OCT 17, 2025
EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region
Gastrointestinal

EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region

SEP 29, 2025